GSTM1 and small cell lung carcinoma: The use of the Hb-to-RDW ratio (HRR)—which merges data coming from the two blood parameters—was first proposed as a prognostic marker in esophageal squamous cell carcinoma patients [4] and later in small cell lung cancer (SCLC) patients [14], emerging as an independent prognostic factor for overall survival (OS) and disease-free survival (DFS).